Kumano et al. [88] demonstrated that iPSCs derived from the primary tumors of two patients with CML exhibited stemness and differentiation to hematopoietic progenitors that expressed BCR–ABL. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.